Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 62(18): 5168-77, 2002 Sep 15.
Article in English | MEDLINE | ID: mdl-12234980

ABSTRACT

Phosphorylation of histone H3 at Ser-10 is required for maintenance of properchromosome dynamics during mitosis. AIM-1, a mammalian Ipl1/aurora kinase involved in H3 phosphorylation, is transcriptionally overexpressed in many tumor cell lines. Increased expression of the AIM-1 gene has been observed in human colorectal tumors of advanced grade and stage. Here we report that forced exogenous overexpression of AIM-1 in Chinese hamster embryo cells causes increased mitotic Ser-10 phosphorylation with concomitant induction of lagging chromosomes during mitosis. Lagging chromosomes could also be induced by transfection with mutated histone H3 (S10E), which is thought to maintain Ser-10 in the phosphorylated state. In the present study, chromosome number instability and increased tumor invasiveness were noted in constitutively AIM-1-overexpressing cells in vivo. Increased mitotic Ser-10 phosphorylation was also observed in various colorectal tumor cells with high AIM-1 expression levels. These data suggest that increased H3 histone phosphorylation as a result of AIM-1 overexpression is a major precipitating factor of chromosome instability and, thus, may play a role in carcinogenesis.


Subject(s)
Aneuploidy , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Histones/metabolism , Protein Kinases/biosynthesis , Protein Serine-Threonine Kinases , Animals , Aurora Kinase B , Aurora Kinases , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Cricetinae , Cricetulus , Fibroblasts/physiology , Mice , Mice, Inbred BALB C , Mice, Nude , Mitosis/genetics , Mitosis/physiology , Phosphorylation , Protein Kinases/genetics , Transfection
2.
Ecotoxicol Environ Saf ; 52(1): 38-45, 2002 May.
Article in English | MEDLINE | ID: mdl-12051806

ABSTRACT

The modifying effects of dietary feeding of estrogenic compounds, 4-nonylphenol (4-NP) and genistein (GS), on 7,12-dimethylbenz[a]anthracene (DMBA)-induced ovarian carcinogenesis were investigated in female Sprague-Dawley rats. We also assessed the effects of test compounds on proliferating cell nuclear antigen (PCNA) index and the expression of estrogen receptor (ER)-alpha and -beta and androgen receptor (AR) in induced neoplasms. Rats were given a single injection of DMBA (0.01 ml of 0.5- DMBA suspended in olive oil) into their left ovary to induce ovarian neoplasms. They also received the experimental diet containing 25 to 250 ppm 4-NP or GS for 50 weeks, starting one week after the dosing of DMBA. DMBA exposure produced ovarian adenocarcinoma with an incidence of 35% at the end of the study (Week 51). Dietary administration of 4-NP or GS caused significant reduction in the incidence of ovarian adenocarcinoma: 86% reduction (P=0.0218) by feeding of 25 or 250 ppm 4-NP and 25 ppm GS, and 100% reduction (P=0.0042) by feeding of 250 ppm GS. The PCNA index in adenocarcinomas was higher than that of surface ovarian epithelium. ER-alpha, beta and AR were expressed in a variable percentage of moderately and poorly differentiated adenocarcinoma cell nuclei, but not in well-differentiated adenocarcinoma cells. These results might suggest that dietary feeding of estrogenic compounds either synthetic (4-NP) or natural (GS) could act as an inhibitor of DMBA-induced rat ovarian carcinogenesis.


Subject(s)
Adenocarcinoma/chemically induced , Adenocarcinoma/prevention & control , Anticarcinogenic Agents/pharmacology , Genistein/pharmacology , Ovarian Neoplasms/chemically induced , Ovarian Neoplasms/prevention & control , Phenols/pharmacology , 9,10-Dimethyl-1,2-benzanthracene/administration & dosage , 9,10-Dimethyl-1,2-benzanthracene/adverse effects , Adenocarcinoma/veterinary , Administration, Oral , Animals , Carcinogens/administration & dosage , Carcinogens/adverse effects , Cell Transformation, Neoplastic , Female , Ovarian Neoplasms/veterinary , Rats , Rats, Sprague-Dawley
3.
Cancer Lett ; 183(2): 131-9, 2002 Sep 26.
Article in English | MEDLINE | ID: mdl-12065087

ABSTRACT

The modifying effect of dietary administration of a diterpenoid furanolactone columbin isolated from the crude drug Calumbae Radix (the root of Jateorhiza columba MIERS, Menispermacea) on azoxymethane (AOM)-induced was investigated in male F344 rats. Animals were initiated with AOM (three weekly subcutaneous injections of 15 mg/kg body weight) to induce colonic neoplasms. They were fed the experimental diets mixed with columbin (4, 20, and 100 ppm) for 4 weeks, starting 1 week before the first dosing of AOM and thereafter maintained on the basal diet without columbin. Additional experimental groups included the AOM alone group, the columbin alone group (100 ppm in diet for 4 weeks), and the untreated control group. Dietary feeding of columbin (4, 20, and 100 ppm) during the initiation phase of AOM-induced colon carcinogenesis reduced the incidence and multiplicity of colonic adenocarcinoma and the inhibition by feeding of 20 ppm (incidence: 20%, P=0.0242 and multiplicity: 0.20+/-0.40, P<0.02) and 100 ppm (incidence: 10%, P=0.0029 and multiplicity: 0.10+/-0.30, P<0.002) columbin was significant when compared with the AOM alone group (incidence: 55% and multiplicity: 0.55+/-0.50). Also, columbin administration in diet lowered the number of argyrophilic nucleolar organizer regions protein per nucleus in non-lesional colonic crypts and the blood polyamine content, which are reflected in cell proliferation activity. These results indicate chemopreventive ability of dietary columbin against chemically induced colon tumorigenesis when fed during the initiation phase, providing a scientific basis for chemopreventive ability of columbin against human colon cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Azoxymethane , Carcinogens , Colonic Neoplasms/chemically induced , Colonic Neoplasms/drug therapy , Diterpenes/chemistry , Diterpenes/pharmacology , Lactones/chemistry , Lactones/pharmacology , Lactones/therapeutic use , Terpenes/therapeutic use , Animals , Cell Nucleus/metabolism , Colon/pathology , Dose-Response Relationship, Drug , Male , Mucous Membrane/pathology , Organ Size , Polyamines/blood , Rats , Rats, Inbred F344 , Time Factors
4.
Ecotoxicol Environ Saf ; 51(3): 210-5, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11971643

ABSTRACT

The modifying effects of dietary feeding of an estrogenic compound 4-n-octylphenol on 3,2'-dimethyl-4-aminobiphenyl (DMAB) induced prostatic carcinogenesis were investigated in male F344 rats. The authors also assessed the effects of test compound on proliferating cell nuclear antigen (PCNA) index in induced neoplasms, hyperplastic lesions, and nonlesional glands in the prostrate. Rats were given intraperitoneal injections of DMAB (25 mg/kg body wt) every other week, 10 times, to induce prostatic neoplasms. They also received the experimental diet containing 10 or 100 ppm 4-n-octylphenol for 20 weeks, starting one week after the last dosing of DMAB. DMAB exposure produced prostatic adenocarcinoma with an incidence of 21% at the end of the study (Week 39). Dietary administration of 4-n-octylphenol did not affect the incidence of prostatic adenocarcinoma: 17% in DMAB-->10 ppm 4-n-octylphenol group; and 12% in DMAB-->100 ppm 4-n-octylphenol group. The PCNA indices in adenocarcinomas, hyperplastic lesions, and nonlesional glands in rats treated with DMAB and 4-n-octylphenol were slightly lower than that of the DMAB alone group, but the differences were not statistically significant. These results might suggest that dietary feeding of the weak estrogenic compound 4-n-octylphenol did not have modulating effects on DMAB-induced rat prostatic carcinogenesis.


Subject(s)
Adenocarcinoma/prevention & control , Aminobiphenyl Compounds/toxicity , Carcinogens/toxicity , Estrogens, Non-Steroidal/therapeutic use , Phenols/therapeutic use , Prostatic Neoplasms/prevention & control , Adenocarcinoma/chemically induced , Adenocarcinoma/chemistry , Adenocarcinoma/pathology , Animals , Diet , Disease Models, Animal , Dose-Response Relationship, Drug , Hyperplasia/chemically induced , Hyperplasia/drug therapy , Hyperplasia/pathology , Immunoenzyme Techniques , Male , Proliferating Cell Nuclear Antigen/analysis , Prostate/chemistry , Prostate/drug effects , Prostate/pathology , Prostatic Neoplasms/chemically induced , Prostatic Neoplasms/chemistry , Prostatic Neoplasms/pathology , Rats , Rats, Inbred F344
SELECTION OF CITATIONS
SEARCH DETAIL
...